跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENLYSTA belimumab 200 mg/mL solution for injection in a pre-filled pen - TGA Drug Approval Details
Approvals
/
TGA
/
BENLYSTA belimumab 200 mg/mL solution for injection in a pre-filled pen
Approved
STANDARD
BENLYSTA belimumab 200 mg/mL solution for injection in a pre-filled pen
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
8c080c4a7be55207
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
8c080c4a7be55207
Product Name
BENLYSTA belimumab 200 mg/mL solution for injection in a pre-filled pen
Artg Id
314922
Artg Name
BENLYSTA belimumab 200 mg/mL solution for injection in a pre-filled pen
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2019-11-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9cc2c577e04fda0e53eeae12e240e0b6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/677c40a736a604c7072e0284c10fac69.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
8c080c4a7be55207
Type
Standard
Back to TGA Approvals